1.	Prediction of the Response to Chemotherapy by Tomoscintigraphie the MIBI in the Balance Sheet Pre Hodgkin's Disease and Lymphoma Malins High Grade Phase: No phase specified Type: Biomarker/Laboratory analysis, Diagnostic Status: Completed Age: Over 18 Sponsor: Other Protocol IDs: I04016, NCT00551798
2.	Paclitaxel and CBT-1(Registered Trademark) to Treat Solid Tumors Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: 080035, 08-C-0035, NCI-08-C-0035, NCT00658424, NCT00972205
3.	Screening in Myocardial Perfusion Patients Phase: No phase specified Type: Diagnostic Status: Closed Age: 18 to 90 Sponsor: Other Protocol IDs: 08-001046, NCT00943241
4.	Hormonal Effects on Tc-99m Sestamibi Uptake in the Breast Phase: No phase specified Type: Diagnostic Status: Completed Age: 35 to 45 Sponsor: Other Protocol IDs: 07-004850, NCT00943527
5.	Pre-biopsy With Dynamic Acquisitions Phase: No phase specified Type: Diagnostic Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: 17-05, BCTR0504394, NCT00943644
6.	Pilot 99mTechnetium-MIBI Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT) in Papillary Carcinoma (CA) Thyroid Phase: No phase specified Type: Diagnostic Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: NapadonChula_01, NCT00984191
7.	The Use of Molecular Breast Imaging in the Evaluation of Tumor Response to Neoadjuvant Therapy in Women With Breast Cancer Phase: No phase specified Type: Diagnostic Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: 09-005183, NCT01023802
8.	Effect of Surgery and Radiation Therapy on Tc-99M Sestamibi Uptake Patterns in Molecular Breast Imaging Phase: No phase specified Type: Natural history/Epidemiology Status: Enrolling by invitation Age: 18 to 90 Sponsor: Other Protocol IDs: 09-000455, NCT01027767